Your browser doesn't support javascript.
loading
Real-World Impact of Switching From Insulin Glargine (Lantus®) to Basaglar® and Potential Cost Saving in a Large Public Healthcare System in Saudi Arabia.
AlRuthia, Yazed; Bahari, Ohud H; Alghnam, Suliman; Alrumaih, Ali M; Asiri, Hassan; Alshammari, Mohammed; Alhowimel, Mansour; Al-Abdulkarim, Hana A.
Afiliação
  • AlRuthia Y; Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
  • Bahari OH; Pharmacoeconomics Research Unit, Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
  • Alghnam S; Department of Pharmaceutical Care, King Saud Medical City, Riyadh, Saudi Arabia.
  • Alrumaih AM; King Abdullah International Medical Research Center (KAIMRC), King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, Saudi Arabia.
  • Asiri H; Pharmaceutical Care Department, Medical Services for Armed Forces, Ministry of Defense, Riyadh, Saudi Arabia.
  • Alshammari M; Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
  • Alhowimel M; Drug Policy and Economic Center, National Guard Health Affairs, Riyadh, Saudi Arabia.
  • Al-Abdulkarim HA; National Unified Procurement Company (NUPCO), Riyadh, Saudi Arabia.
Front Public Health ; 10: 852721, 2022.
Article em En | MEDLINE | ID: mdl-35769787
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Temas: ECOS / Aspectos_gerais / Financiamentos_gastos Bases de dados: MEDLINE Assunto principal: Medicamentos Biossimilares Tipo de estudo: Health_economic_evaluation / Observational_studies Limite: Adult / Female / Humans / Male País/Região como assunto: Asia Idioma: En Revista: Front Public Health Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Arábia Saudita
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Temas: ECOS / Aspectos_gerais / Financiamentos_gastos Bases de dados: MEDLINE Assunto principal: Medicamentos Biossimilares Tipo de estudo: Health_economic_evaluation / Observational_studies Limite: Adult / Female / Humans / Male País/Região como assunto: Asia Idioma: En Revista: Front Public Health Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Arábia Saudita